About Enigma Genetics

Our Mission

Enigma Genetics is building the world's first self-sovereign genetic identity platform. We believe that individuals should have complete ownership and control over their most personal data—their DNA. Through our patent-pending technology, we're creating a new paradigm where genetic information is secured, privacy-preserved, and ethically monetized on the individual's terms.

The Problem

Today, genetic data is routinely collected, stored, and exploited by corporations without meaningful individual control. Once submitted to a commercial DNA testing service, your genetic information becomes a commodity—sold to pharmaceutical companies, shared with researchers, and potentially accessed by law enforcement, often without your explicit consent.

The $40B+ genomics industry profits immensely from this data, while individuals receive little to no compensation and have minimal transparency into how their information is used.

Our Solution

Enigma Genetics integrates five core technologies into a seamless, secure platform:

• •Cypherglyph™: A cryptographic genetic identity system that transforms DNA data into secure, verifiable digital identities
• •GeneVault™: Encrypted personal genomic data storage with granular access controls
• •SignaChain™: Consent-based data exchange protocol ensuring transparency in every transaction
• •Unifacator™: Interoperable framework connecting healthcare systems, research institutions, and biobanks
• •OmniMind™: AI-driven epigenetic insights and personalized health analytics

Our Vision

We envision a future where genetic data ownership is a fundamental human right. A world where individuals control who accesses their DNA, for what purpose, and at what price. Where researchers gain access to richer, consent-backed datasets. Where healthcare becomes truly personalized and privacy-preserving. Enigma Genetics is building that future, one cryptographic identity at a time.

Leadership

Enigma Genetics is led by a multidisciplinary team combining expertise in molecular biology, cryptography, blockchain architecture, artificial intelligence, and bioethics. Together, we're pioneering the next generation of genetic data infrastructure.